Idaho Mine May Become Only U.S. Domestic Source of Sb
Source: Mike Niehuser 09/04/2024
The final record of decision regarding this past-producing operation is due to be completed by the end of this year, noted a ROTH Capital Partners report.
Perpetua Resources Corp.’s (PPTA:TSX; PPTA:NASDAQ) Stibnite gold project in Idaho may become the U.S.’ sole domestic source of antimony, the need for such intensified by China’s imminent export restrictions on the metal, reported ROTH Capital Partners analyst Mike Niehuser in a September 3 research note.
“Assuming the current timeline, which includes timely receipt of permits and no litigation, the Stibnite gold project may commence production in 2028,” Niehuser wrote. “Perpetua remains confident that the final record of decision will be received by year-end [2024].”
Rating is Buy
ROTH reiterated its 12-month target price of US$10 per share on the U.S. explorer-developer, trading at the time of the article at about US$8.90 per share, noted Niehuser.
From the current price, the target reflects an uplift of 12.4%.
Perpetua remains a Buy.
The Problem in a Snapshot
The U.S., lacking a domestic supplier, is running on low on antimony, a critical metal, and its primary source, China, is about to limit how much it will export to the States, Niehuser explained.
Last year, the U.S. consumed 22,000 tons of antimony, and the National Defense Stockpile contained only 1,100 tons of it, according to the U.S. Geological Survey, Niehuser pointed out. The U.S. needs antimony for its wide range of military applications, including 300-plus types of munitions.
The U.S. gets about 63% of its antimony from China, which intends to start restricting exports of the metal to the Western country starting September 15. These controls are needed, according to China’s ministry of commerce, “to further protect China’s national security and interests and fulfill the nation’s international non-proliferation obligations.”
“In our opinion, this is a strategic move by China to diminish U.S. capabilities with ongoing conflicts in Ukraine, the Middle East, and potentially Taiwan,” Niehuser wrote.
Half of the world’s antimony comes from China, which has about 32% of the global antimony reserves and about 48% of global mine production, USGS data indicate. Other countries producing antimony are Australia, Russia, Burma, Tajikistan and Turkey.
Two of the U.S.-friendly countries, Tajikistan and Australia, have substantial reserves and mine production but rely on China to process a large percentage of their concentrate, 78% and 86%, respectively. Thus, the bottleneck in the global antimony supply seems to be in processing and refining, Niehuser wrote.
A Potential Solution
Perpetua’s Stibnite gold project has about 148,700,000 tons of antimony, enough to backstop about half of U.S. domestic antimony consumption for six years, based on USGS data from 2023, purported Niehuser.
“While any increase in antimony prices may marginally improve project economics, certainly relative to a sustained increase in the gold price, we believe that antimony’s critical contribution to national defense should be a top interest of the Administration,” the analyst wrote.
The price of antimony, specifically antimony trisulfide (Sb2S3, or stibnite), likely will remain elevated given the U.S. Department of Defense’s unrelenting need for it, Niehuser added.
Sign up for our FREE newsletter at: www.streetwisereports.com/get-news
Important Disclosures:
- Perpetua Resources Corp. is a billboard sponsor of Streetwise Reports and pays SWR a monthly sponsorship fee between US$4,000 and US$5,000.
- Doresa Banning wrote this article for Streetwise Reports LLC and provides services to Streetwise Reports as an independent contractor.
- This article does not constitute investment advice and is not a solicitation for any investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Each reader is encouraged to consult with his or her personal financial adviser and perform their own comprehensive investment research. By opening this page, each reader accepts and agrees to Streetwise Reports’ terms of use and full legal disclaimer. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company.
For additional disclosures, please click here.
Disclosures Roth MKM, Perpetua Resources Corp., September 3, 2024
Regulation Analyst Certification (“Reg AC”): The research analyst primarily responsible for the content of this report certifies the following under Reg AC: I hereby certify that all views expressed in this report accurately reflect my personal views about the subject company or companies and its or their securities. I also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report.
Disclosures: ROTH Capital Partners, LLC expects to receive or intends to seek compensation for investment banking or other business relationships with the covered companies mentioned in this report in the next three months. The material, information and facts discussed in this report other than the information regarding ROTH Capital Partners, LLC and its affiliates, are from sources believed to be reliable, but are in no way guaranteed to be complete or accurate. This report should not be used as a complete analysis of the company, industry or security discussed in the report. Additional information is available upon request. This is not, however, an offer or solicitation of the securities discussed. Any opinions or estimates in this report are subject to change without notice. An investment in the stock may involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Additionally, an investment in the stock may involve a high degree of risk and may not be suitable for all investors. No part of this report may be reproduced in any form without the express written permission of ROTH. Copyright 2024. Member: FINRA/SIPC.
( Companies Mentioned: PPTA:TSX; PPTA:NASDAQ, )
Source: https://www.streetwisereports.com/article/2024/09/04/idaho-mine-may-become-only-u-s-domestic-source-of-sb.html
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
LION'S MANE PRODUCT
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.